Dolutegravir 50mg od

DRUG2 trials

Sponsors

University of Liverpool

Conditions

HIVMalariaPregnancy

Phase 1

Dolutegravir Interactions With Artemisinin-based Combination Therapies

CompletedNCT02242799

University of LiverpoolHIV, Malaria

Start: 2015-06-30End: 2016-09-30Updated: 2016-10-05

Phase 2

Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study

CompletedNCT02245022

University of LiverpoolHIV, Pregnancy

Start: 2017-03-14End: 2018-12-06Updated: 2025-09-04

Related Papers

Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1

Clinical Infectious Diseases2020-12-1524 citations

Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)

PLoS Medicine2019-09-20104 citations

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.

2019-01-2921 citations